European Journal of Human Genetics (2001) 9, 797 ± 801
ã 2001 Nature Publishing Group All rights reserved 1018-4813/01 $15.00www.nature.com/ejhg
The angiotensin converting enzyme I/D polymorphism
Igor B Nazarov*,1,3, David R Woods2, Hugh E Montgomery2, Olga V Shneider1,3,
Vasiliy I Kazakov1, Nikolai V Tomilin1 and Viktor A Rogozkin3
1Institute of Cytology of the Russian Academy of Sciences, Tikchoretski Ave. 4, Saint Petersburg, 194064, Russia;
2Department of Cardiovascular Genetics, 3rd floor Rayne Institute, University College London, 5 University Street,
London WC1E 6JJ, UK; 3Saint-Petersburg Scientific Research Institute of Physical Culture, 2 Dinamo Street, Saint
The deletion (D) allele of the human ACE gene is associated with higher ACE activity than the insertion (I)
allele. There is controversy as to whether the ACE genotype may be associated with elite athletic status; recent
studies have identified no significant associations amongst those drawn from mixed sporting disciplines.
However, such lack of association may reflect the mixed nature of such cohorts, given that an excess frequency
of the I allele has been reported amongst elite endurance athletes, and an excess of the D allele amongst those
engaged in more power-orientated sports. We examined this hypothesis by determining ACE I/D allele
frequency amongst 217 Russian athletes (swimmers, skiers, triathletes and track-and-field participants)
prospectively stratified by performance (`outstanding' or `average'), and the duration of their event (SDA
(51 min), MDA (1 to 20 min), and LDA (420 min): short, middle and long distance athletes respectively). ACE
genotype and allele frequencies were compared to 449 controls. ACE genotype frequency amongst the whole
cohort, or the outstanding athletes alone, was no different to that amongst sedentary controls. However,
there was an excess of the D allele (frequency 0.72, P=0.001) amongst the outstanding SDA group, and an
excess of the I allele (frequency 0.63, P=0.032) amongst the outstanding MDA group. These findings were
replicated in the outstanding swimmers, with track and field SDA similarly demonstrating an excess of the D
allele (P=0.01). There was no association found between the outstanding LDA and ACE genotype (P=0.27).
These data not only confirm an excess of the D allele in elite SDA, and I allele in elite MDA, but also offer an
explanation as to why any such association may be hard to detect amongst a heterogeneous cohort of mixed
athletic ability and discipline. European Journal of Human Genetics (2001) 9, 797 ± 801.
Keywords: angiotensin converting enzyme; ACE; athletes; sport
An excess of the I allele has been associated with some
A polymorphism in intron 16 of the human angiotensin I-
aspects of endurance performance, being identified in elite
converting enzyme (ACE) gene has been identified in which
British distance runnersand mountaineers.In addition, an
the presence (insertion, I allele) rather than the absence
excess of the I allele is present in Australianand Croatian
(deletion, D allele) of a 287 bp Alu-sequence insertion
rowers as well as Spanish elite athletes.Conversely, an excess
fragment is associated with lower serumand ACE
of the D allele has been reported amongst elite athletes in
more power-oriented events such as short distance swim-mingand
However, there has been debate as to the reproducibility of
*Correspondence: Igor B Nazarov, Med. Biological Chemistry, 4107
such associations. Several studies have failed to identify any
Tupper Hall, One Shields Avenue, University of California at Davis, Davis,
association with elite endurance performance.Taylor et
CA 95616, USA. Tel: +1 530 7525913; Fax: +1 530 7523516;
alexamined hockey players, cyclists, skiers, track and field
Received 2 April 2001; revised 28 June 2001; accepted 5 July 2001
athletes, swimmers, rowers, gymnasts and `others'. Similarly,
ACE genotype frequencies in Russian athletes
the mixed cohort examined by Karjalainenincluded
`Outstanding' athletes (n=141) were at least national
diverse sports such as long distance running, orienteering,
representatives. This group included 81 European and
cross country skiing and triathlon. The 192 athletes studied
Russian champions and 19 Olympic or World champions.
by Rankinen et alalso included skiers, long and middle
`Average' athletes (n=76) were regional competitors with
distance runners, cyclists and biathletes (the latter would also
no less than 7 years experience participating in their sport,
have to to demonstrate more than a proficiency at rifle
but who had never been selected for the national team.
marksmanship). Such studies thus comprise individuals
This may have introduced unintended selection bias but
selected from diverse sporting disciplines, with potential
was fundamental to the study aim. In order to further
variation in standard, with events of varying duration and
avoid selection bias, three methods were used to recruit
the outstanding athletes; targeting of national teams,
In general, therefore, the association of ACE genotype with
information provided by national coaching staff, and
sporting prowess is recognised in studies of elite athletes
athletes attending national training camps.
Controls consisted of 449 healthy unrelated volunteers
(111 students of St Petersburg University, aged 18 ± 20, and
338 blood donors, age 25 ± 45). The athletes and control
groups were all Caucasian Russians, with an equivalent ratio
from European and Siberian descent (3 : 1 in both groups).
We have tested this hypothesis in the study of a mixed
Further characteristics are presented in
cohort of Russian athletes. ACE gene I/D allele frequencies forthe cohort overall were first compared to those in a control
sample. Subsequently, allele frequency was compared across
DNA was extracted from white blood cells or mouthwash
event duration in individual sporting disciplines, for those
samples as previously described.ACE genotype was
determined using a three-primer method,yielding ampli-fication products of 65 bp (I allele) and 84 bp (D allele). Thesewere separated by electrophoresis on a 7.5% polyacrylamide
gel and visualised using ethidium bromide. Genotyping was
The University of St Petersburg Ethics Committee approved
performed by experienced staff blind to subject data.
the study and written informed consent was obtained fromeach participant.
Statistical analysisAllele frequencies were determined by gene counting.
Genotype distribution and allele frequencies between groups
Two hundred and seventeen male and female Russian
of athletes and controls were then compared by w2 test. P
athletes of regional or national competitive standard were
values of 50.05 were considered statistically significant. By a
recruited from the following sports: swimming (n=66), track-
priori hypothesis, primary independent analyses explored
and-field athletics (n=81), cross-country skiing (n=52), and
differences in allele frequency between mixed athletes and
controls, and by event duration in truly elite athletes
Our a priori intention was to clarify whether previously
competing in sports in which an association had been
documented associations between the ACE polymorphism
and elite athletes found in the study of a single sportingdiscipline could be duplicated in Russian athletes. Sec-ondly, we wanted to determine whether negative studies
Table 1 ACE genotype distribution of the athletes and
that have found no association were due to the combining
controls with sex (frequencies) and age (average+SE)
of athletes from different sports with different elements ofpower/endurance (anaerobic/aerobic) activity. The athletes
were therefore prospectively stratified into groups accord-ing to event duration, covering a spectrum from the more
`power'-oriented to the more endurance-oriented. SDA
(short distance athletes) consisted of `sprinters', performing
their given task in under 1 min (predominantly anaerobic
energy production). MDA (middle distance athletes) were
those competing over 1 to 20 min (mixed anaerobic and
aerobic energy production), and LDA (long distance
athletes) were those performing over more than 20 min
(aerobic). The athletes were further classified by their
standard of competition based on previous performances.
ACE genotype frequencies in Russian athletes
confined to the elite swimmers and were not replicated
The subjects' age, male/female ratio and years in their
chosen sport did not differ by ACE genotype
The track and field athletes demonstrated an excess of the
ACE genotype distributions amongst subjects and controls
D allele in outstanding SDA (P=0.01), with an excess of the
were in Hardy-Weinberg equilibrium, being similar to that
DD genotype (P=0.018), which was not present in the average
Figure 1 I and D allele frequencies in 141 outstanding Russian
athletes, by duration of event, and sedentary controls. As
In considering individual sporting disciplines the
hypothesised, the overall cohort of `outstanding' athletes failed
mixed cohort of average and elite swimmers again demon-
to demonstrate any association with the ACE genotype (P=0.78,
strated no association with the ACE genotype (P=0.67).
and 0.55 by w2 test compared to controls, for genotype and
allele frequency respectively). However, ACE genotype was
However, again examining allele frequencies by duration of
associated with event duration: an excess of D alleles (P=0.001)
event, a significant excess of the D allele was evident in the
being noted in the SDA (short-distance athletes) group, and an
SDA (P=0.042), with an excess of the I allele in the MDA
elevated frequency of the I allele in the MDA (middle-distance
(P=0.042). As previously reported these findings were
Table 2 ACE genotype distribution and frequencies of ACE gene D allele in athletes stratified by sporting discipline, standard
and duration of event. Comparison with controls was by w2 test
*P50.05, **P50.02. SDA, short distance athletes; MDA, middle distance althletes; LDA, long distance athletes.
ACE genotype frequencies in Russian athletes
athletes. These were responsible for the significant excess of
former elite, but not the average, MDA. This emphasises the
the DD genotype (P=0.043), and D allele (P=0.018), in track
need to examine outstanding athletes with stratification by
the nature and duration of the event.
There was no relationship with ACE genotype amongst the
The lack of an association between ACE genotype and elite
skiers and triathletes may help explain the failure to find anexcess of the I allele in other cohortswhich haveincluded a substantial proportion of such athletes. I allele-
associated endurance may be an important, but not prime,
These data confirm our hypothesis that the study of a
determinant of success in cross-country skiing and the
mixed cohort of athletes from various sporting disciplines,
triathlon. A cohort such as that previously which
or the inclusion of non-elite athletes, may result in failure
includes swimmers and track and field athletes, without
to demonstrate an association between elite athletes and
deference to event duration, is even less likely to demonstrate
the ACE genotype. However, in considering only out-
an ACE genotype effect, especially in light of the excess of D
standing athletes by duration of event (and hence relative
alleles in short distance swimmers and track and field athletes
contribution of anaerobic/power component compared to
aerobic/endurance), we confirm an excess of the D allele
Although the D allele has been associated with greater
in the SDA with an excess of the I allele in the MDA.
training-related changes in left ventricular and VO2
Such findings are consistent with those previously
max risethe mechanism underlying the association of the
D allele with power oriented, anaerobic sports is most likely
Statistical adjustment for multiple comparison was not
mediated through differences in skeletal muscle strength
required in this study, as separate primary analysis for a single
gain. A greater training-related increase in quadriceps muscle
gene were performed according to a priori criteria, which
strength has been associated with the D Such effects
aimed to confirm previously-identified associations.
may, in turn, depend upon increased ACE-mediated activa-
It is interesting that we failed to demonstrate an excess of
tion of the growth factor angiotensin II,and increased
the I allele in the outstanding long-distance athletes, and
hence did not find an increasing linear trend of I allele with
sely, the I allele may influence endurance performance
increasing aerobic component as has previously been
through improvements in substrate deliveryand the
This may relate to differences in categorising
efficiency of skeletal muscle,with subsequent conservation
athletes; Myerson et alexamined allele frequency by
distance; 200 m, 400 ± 3000 m, and symbol 55000 m,
The II genotype is strongly associated with lower ACE
whereas in this study we categorised athletes by duration of
activity,perhaps caused by an Alu associated transcription
event (under 1 min, 1 to 20, and over 20 min). This was done
silencer,or by an unidentified polymorphic variant of
to enable reasonable comparison between outstanding
the ACE gene promoter in linkage disequilibrium with the I
athletes of different disciplines and in order to account for
alleleIndeed, the gene for growth hormone lies in close
the different times taken to complete the same distance. An
proximity. Although linkage to the ACE I/D polymorphic site
elite cross country skier will complete the 5000 m in around
seems unlikely,a physiological interaction seems possible
12 min, an elite 5000 m runner in around 13 (current world
as elevated angiotensin II stimulates growth hormone release
record 12 m in 39 s). However, a swimmer will have only
in humansvia the angiotensin II type 1 receptor
completed less than 1500 m by similar time points (the
In conclusion, these data support the suggestion that
current swimming world 1500 m record being 14 min 41 s).
subsequent studies might best focus upon only truly elite
Hence, a 5000 m runner or skier would be categorised as a
athletes, that only those of a single sporting discipline should
MDA by our criteria, but a long distance competitor by the
be considered, and that cohort stratification should be
criteria of Myerson et al.Indeed, only the symbol 55000 m
undertaken in some fashion according to anaerobic/aerobic
runners reported by Myerson et al showed an excess of I
or power/endurance component, as has been previously
alleles compared to controls,which equates to our similar
descriThe ACE I/D polymorphism should not be
finding in outstanding MDA (I allele frequency 0.62 and 0.63,
considered a `gene for human performance', but a marker of
respectively). Secondly, there was no excess of I alleles in
modulation such that one would expect association only in
symbol 55000 m runners when compared to middle
the truly elite athlete according to the nature of the specific
distance athletes in the cohort of Myerson et alThe trend
of rising I allele frequency, from short to longer distance,partly reflects an excess of the D allele in anaerobic events,which we have confirmed.
Important additional findings include the excess of D
We thank Valentina Saburova for technical assistance. This work was
alleles amongst only the outstanding SDA swimmers, and
supported by grants from the Russian Fund for Basic Research 00-04-
track and field athletes, with an excess of the I allele in the
ACE genotype frequencies in Russian athletes
15 Rankinen T, Perusse L, Gagnon J et al. Angiotensin-converting
1 Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier
enzyme ID polymorphism and fitness phenotype in the
F. An insertion/deletion polymorphism in the angiotensin-1-
HERITAGE Family Study. J Appl Physiol 2000; 88: 1029 ± 1035.
converting enzyme gene accounting for half the variance of
16 Folland J, Leach B, Little T et al. Angiotensin-converting enzyme
serum enzyme levels. J Clin Invest 1990; 86: 1343 ± 1346.
genotype affects the response of human skeletal muscle to
2 Danser AHJ, Schalekamp MADH, Bax WA et al. Angiotensin
functional overload. Exp Physiol 2000; 85: 575 ± 579.
converting enzyme in the human heart: effect of the deletion/
17 Brown NJ, Blais C, Gandhi SK, Adam A. ACE Insertion/Deletion
insertion polymorphism. Circulation 1995; 92: 1387 ± 1388.
Genotype Affects Bradykinin Metabolism. J Cardiovasc Pharma-
3 Myerson S, Hemingway H, Budget R, Martin J, Humphries S,
Montgomery H. Human angiotensin I-converting enzyme gene
18 Liu Y, Leri A, Li B et al. Angiotensin II stimulation in vitro
and endurance performance. J Appl Physiol 1999; 87: 1313 ±
induces hypertrophy of normal and postinfarcted ventricular
myocytes. Circ Res 1998; 82: 1145 ± 1159.
4 Montgomery HE, Marshall RM, Hemingway H et al. Human gene
19 Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Angiotensin-
for physical performance. Nature 1998; 393: 221 ± 222.
converting enzyme insertion/deletion polymorphism modu-
5 Gayagay G, Yu B, Hambly B et al. Elite endurance athletes and
lates the human in vivo metabolism of bradykinin. Circulation
the ACE I allele ± the role of genes in athletic performance. Hum
20 Linz W, Scholkens BA. A specific B2-bradykinin receptor
6 Jelakovic B, Kuzmanic D, Milicic D et al. Influence of
antagonist HOE 140 abolishes the antihypertrophic effect of
angiotensin converting enzyme (ACE) gene polymorphism
ramipril. Br J Pharmacol 1992; 105: 771 ± 772.
and circadian blood pressure (BP) changes on left ventricle
21 Woods DR, Humphries SE, Montgomery HE. The ACE I/D
(LV) mass in competitive oarsmen. Am J Hypertens 2000; 13:
Polymorphism and Human Physical Performance. Trends
Endocrinol Metab 2000; 11: 416 ± 420.
7 Alvarez R, Terrados N, Ortolano R et al. Genetic variation in the
22 Williams AG, Rayson MP, Jubb M et al. The ACE gene and muscle
renin-angiotensin system and athletic performance. Eur J Appl
23 Montgomery H, Clarkson P, Barnard M et al. Angiotensin-
8 Woods D, Hickman M, Jamshidi Y et al. Elite swimmers and the
converting-enzyme gene insertion/deletion polymorphism and
D allele of the ACE I/D polymorphism. Hum Genet 2001; 108:
response to physical training. Lancet 1999; 353: 541 ± 545.
24 Tomilin NV, Iguchi-Ariga SM, Ariga H. Transcription and
9 Taylor RR, Mamotte CDS, Fallon K, Bockxmeer FM. Elite athletes
replication silencer element is present within conserved region
and the gene for angiotensin-converting enzyme. J Appl Physiol
of human Alu repeats interacting with nuclear protein. FEBS Lett
10 Karjalainen J, Kujala UM, Stolt A et al. Angiotensinogen Gene
25 Tomilin NV. Control of genes by mammalian retroposons. Int
M235T polymorphism predicts left ventricular hypertrophy in
endurance athletes. J Am Coll Cardiol 1999; 34: 494 ± 499.
26 Rieder MJ, Taylor SL, Clark AG, Nickerson DA. Sequence
11 Rankinen T, Wolfarth B, Simoneau J et al. No association
variation in the human angiotensin converting enzyme. Nat
between the angiotensin-converting enzyme ID polymorphism
and elite endurance athlete status. J Appl Physiol 2000; 88:
27 McKenzie CA, Julier C, Forrester T et al. Segregation and linkage
analysis of serum angiotensin I-converting enzyme levels:
12 Bolla MK, Haddad L, Humphries SE, Winder AF, Day INM. A
evidence for two quantitative trait loci. Am J Hum Genet 1995;
method for determination of hundreds of APOE genotypes
utilising highly simplified, optimised protocols and restriction
28 Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM.
digestion analysis by microtitre array diagonal gel electrophor-
Absence of linkage between the angiotensin converting enzyme
esis (MADGE). Clin Chem 1995; 41: 1599 ± 1604.
locus and essential hypertension. Nat Genet 1992; 1: 72 ± 75.
13 O'Dell SD, Humphries SE, Day INM. Rapid methods for
29 Messerli FH, Nowaczynski W, Honda M et al. Effects of
population-scale analysis for gene polymorphisms: the ACE
angiotensin II on steroid metabolism and hepatic blood flow
gene as an example. Br Heart J 1995; 73: 368 ± 371.
in man. Circ Res 1977; 40: 204 ± 207.
14 Montgomery HE, Clarkson P, Dollery CM et al. Association of
30 Coiro V, Volpi R, Capretti L et al. Stimulation of ACTH and GH
Angiotensin-Converting Enzyme Gene I/D polymorphism with
release by angiotensin II in normal men is mediated by the AT1
change in left ventricular mass in response to physical training.
receptor subtype. Regul Pept 1998; 74: 27 ± 30.
LES GLITAZONES ont été retirées du marché, LES GÉNÉRIQUES en juin 2011 pour l’ACTOS® et en 2010 pour l’AVANDIA®. Un laboratoire pharmaceutique a l’exclusivité d’une molécule qu’il a découvert pendant un LES GLINIDES certain nombre d’années. Puis elle tombe dans le domaine public et peut être fabriquée sous la forme générique à un moindre coût.
Dr. Norbert Guggenbichler, Louisenstr. 19, 61348 Bad Homburg v.d.H. Dr. Guggenbichler, Louisenstr. 19, 61348 Bad HomburgAnHerrn Prof. Dr. Dr. LauterbachDeutscher BundestagPlatz der Republik 111011 Berlin Offener Brief zur Forderung der Streichung von Aufwendungen für HomöopathieSehr geehrter Herr Prof. Dr. Dr. Lauterbach,Danke für Ihre Antwort auf meine E-mail vom 13.7. 2010. Sie schrie